<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl3">
 <label>Table 3</label>
 <caption>
  <p>Antiviral drugs for COVID-19 recommended in the guidelines of the NHC</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Medication instruction</th>
    <th>Alpha-interferon</th>
    <th>Lopinavir/ritonavir</th>
    <th>Ribavirin</th>
    <th>Chloroquine</th>
    <th>Arbidol</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Recommended dosage and course</td>
    <td>5 million units or equivalent dose per time for adults, adding 2 mL of sterile water, aerosol inhalation, twice per day.
     <break/>For children,
     <xref rid="tbl3fnlowast" ref-type="table-fn">∗</xref> 100,000-200,000 IU/kg in mild cases, 200,000-400,000 IU/kg in severe cases, twice per day for 5-7 days.
    </td>
    <td>200 mg/50 mg per capsule, 2 capsules each time, twice per day for adults. The course of treatment should be ≤ 10 days.
     <break/>For children,
     <xref rid="tbl3fnlowast" ref-type="table-fn">∗</xref> weight 7-15 kg, (12 mg/3 mg)/kg; weight 15-40 kg, (10 mg/2.5 mg)/kg; weight &gt; 40 kg, same as adults.
    </td>
    <td>Combining with alpha-interferon or lopinavir/ritonavir, 500 mg for adults per time, intravenous injection 2-3 times per day. The course of treatment should be ≤ 10 days.
     <break/>For children,
     <xref rid="tbl3fnlowast" ref-type="table-fn">∗</xref> 10 mg/kg per time (maximum 500 mg per time), intravenous injection 2-3 times per day.
    </td>
    <td>Only for adults aged 18-65 y.
     <break/>Weight &gt; 50 kg, 500 mg per time, twice per day for 7 days.
     <break/>Weight &lt; 50 kg, 500 mg per time, twice per day for 2 days and then 500 mg per time, once per day for 5 days.
    </td>
    <td>200 mg for adults, 3 times per day. The course of treatment should be ≤ 10 days.</td>
   </tr>
   <tr>
    <td>Medication for special populations</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
   </tr>
   <tr>
    <td> Children</td>
    <td>Recommended</td>
    <td>Recommended for children &gt; 2 y old</td>
    <td>Recommended</td>
    <td>Not recommended</td>
    <td>Unclear</td>
   </tr>
   <tr>
    <td> Pregnant/lactating women</td>
    <td>Prudent use</td>
    <td>Recommended</td>
    <td>Forbidden</td>
    <td>Prudent use in lactating women</td>
    <td>Unclear</td>
   </tr>
   <tr>
    <td> Elderly</td>
    <td>Recommended</td>
    <td>Safety unclear; prudent use</td>
    <td>Not recommended</td>
    <td>Unclear</td>
    <td>Unclear</td>
   </tr>
   <tr>
    <td> Liver dysfunction patients</td>
    <td>Prudent use</td>
    <td>Prudent use</td>
    <td>Prudent use</td>
    <td>Prudent use</td>
    <td>Unclear</td>
   </tr>
   <tr>
    <td> Renal dysfunction patients</td>
    <td>Prudent use</td>
    <td>Recommended</td>
    <td>CCR &lt; 50 mL/min: not recommended</td>
    <td>Prudent use</td>
    <td>Prudent use in severe renal dysfunction</td>
   </tr>
   <tr>
    <td>Contraindication</td>
    <td>Patients with severe liver/renal dysfunction</td>
    <td>Patients with severe liver dysfunction</td>
    <td>Pregnant/lactating women</td>
    <td>Pregnant women</td>
    <td>Unclear</td>
   </tr>
   <tr>
    <td>Approved indications</td>
    <td>Broad-spectrum antiviral, immunomodulatory, and antitumor</td>
    <td>HIV-1 infection</td>
    <td>Respiratory syncytial virus pneumonia</td>
    <td>Malaria</td>
    <td>A and B influenza viruses</td>
   </tr>
   <tr>
    <td>Adverse reactions</td>
    <td>
     <xref rid="tbl3fndagger" ref-type="table-fn">†</xref>
    </td>
    <td>
     <xref rid="tbl3fndagger" ref-type="table-fn">†</xref>
    </td>
    <td>
     <xref rid="tbl3fndagger" ref-type="table-fn">†</xref>
    </td>
    <td>
     <xref rid="tbl3fndagger" ref-type="table-fn">†</xref>
    </td>
    <td>
     <xref rid="tbl3fndagger" ref-type="table-fn">†</xref>
    </td>
   </tr>
   <tr>
    <td>Off-label drug use</td>
    <td/>
    <td>Yes</td>
    <td>Yes</td>
    <td>Yes</td>
    <td>Yes</td>
   </tr>
   <tr>
    <td>Clinical trials
     <xref rid="tbl3fnddagger" ref-type="table-fn">‡</xref>
    </td>
    <td>6</td>
    <td>9</td>
    <td>1</td>
    <td>16</td>
    <td>3</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>CCR, creatinine clearance rate; NHC, National Health Commission; HIV, human immunodeficiency virus.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl3fnlowast">
   <label>∗</label>
   <p id="ntpara0060">The guidelines of the NHC did not recommend the dosage and course for children. The recommended dosage and course of the drugs for children in the table are from Chen et al.’s studies.
    <xref rid="bib36" ref-type="bibr">
     <sup>36</sup>
    </xref>
   </p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl3fndagger">
   <label>†</label>
   <p id="ntpara0065">Refer to product guidelines for specific information.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl3fnddagger">
   <label>‡</label>
   <p id="ntpara0070">The number of clinical trials of COVID-19 in China as of April 3, 2020. Data from 
    <ext-link ext-link-type="uri" xlink:href="http://www.chictr.org.cn/" id="intref0065" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.chictr.org.cn/</ext-link>.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
